Lupin Pharmaceuticals, Inc.

Lupin Launches Raltegravir Tablets, USP, 600 mg in the United States

As the First-To-File, Lupin is Eligible for 180-Day Generic Exclusivity MUMBAI, India and NAPLES, Fla., Nov. 3, 2026 — Global pharmaceutical leader…